Eric Topol

Would you say, oh, go ahead?

Yeah, so everything needs to be individualized.

That's a theme here.

This is one of the most complicated things in medicine.

I'm glad you're on it, but with all the different variables of the preparations, combinations,

the risk of the person that you're talking to, the time duration, the time lapse from menopause.

There's so many complexities and nuances here.

That's why there aren't enough clones of you out there with the information at hand.

And there's lots of,

Oh, well, good.

Now, right now, we're seeing big resources from philanthropists going into women's health, and obviously, this is part of it.

And not just menopause, perimenopause, premenopause.

I mean, all things women's health, which is great since this has been an area that is mixed up and had some miscues.

What are your thoughts about that?

Well, speaking of PCOS, polycystic ovary syndrome, we've seen all these so-called ozempic babies on GLP-1.

That is a treatment for PCOS.

Any comments about not just that drug, but the whole family of drugs in use in women?

Sure.

No, I get it.

I'm glad you can have limits of where you would consider your expertise or knowledge base.